Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol Succinate in Thalassemia Cardiomyopathy
NCT01863173Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2012
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiomyopathy comparing Metoprolol with Placebo (2 arms). Primary endpoints: Left Ventricular Ejection Fraction at 6 months, 6-Minute Walk Test at 6 months and 1 more. Started Jan 2012; status: completed.
02
Drugs
metoprolol
03
Conditions
cardiomyopathy
Beyond the preview
Go deeper on NCT01863173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863173.